Granules India Ltd. has initiated a voluntary recall of over 2.3 crore tablets of Ranitidine 150 mg in the US market because of the presence of...
Biocon Ltd. has appointed MB Chinappa as chief financial officer (CFO) of its subsidiary Biocon Biologics India Ltd. Chinappa joins Biocon Biologics from Biocon’s subsidiary company,...
Forendo Pharma, a clinical-stage drug development company focusing on novel treatments in women’s health, has signed a license-and-collaboration agreement with Novartis. The joint research collaboration is...
Merck, through a subsidiary, is commencing a cash tender offer to purchase all outstanding shares of common stock of ArQule, Inc. On December 9, 2019, Merck...
Mankind Pharmaceuticals has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Under the sub-licensing agreement, Mankind will market...
The US Food and Drug Administration (FDA) has accepted the Novartis’ supplemental Biologics License Application (sBLA) for Xolair (Omalizumab) for the treatment of nasal polyps in...
BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies for cancer immunotherapy, and Transgene, a biotech company...
The US Food and Drug Administration (FDA) approved Atezolizumab (Tecentriq, Genentech/Roche) in combination with chemotherapy nab-paclitaxel (Abraxane, Celgene) and carboplatin for the first-line treatment of metastatic...
The US Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis...
The US Food and Drug Administration has declined Enzyvant’s regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing. The company was...
Glenmark Pharmaceuticals Inc. has been granted abbreviated new drug application (ANDA) approval by the US Food & Drug Administration (USFDA) for its Abiraterone Acetate tablets USP,...
Cipla has acquired a patented anti-infective drug Elores from Venus Remedies Ltd. The product is used for the treatment of life-threatening infections caused by certain bacteria....
Sun Pharma’s subsidiary has launched Drizalma Sprinkle in the US. It is the first and only USFDA-approved sprinkle formulation of Drizalma Sprinkle, which is delayed-release duloxetine...
GlaxoSmithKline plc has announced a five-year collaboration with Lyell Immunopharma to develop new technologies to improve cell therapies for cancer patients. The collaboration will apply Lyell’s...
Shield Healthcare has acquired Brio Bliss Life Science and Nutri Synapzz Therapeutics. Following the acquisitions, Shield Healthcare aims to increase its presence in gynecology and pediatrics....
Copyright © 2023 Medical Buyer